These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9723826)

  • 1. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.
    Pawlotsky F; Thomas A; Kergueris MF; Debillon T; Roze JC
    Br J Clin Pharmacol; 1998 Aug; 46(2):163-7. PubMed ID: 9723826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
    James JK; Palmer SM; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
    Covajes C; Scolletta S; Penaccini L; Ocampos-Martinez E; Abdelhadii A; Beumier M; Jacobs F; de Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
    Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.
    Hill LF; Turner MA; Lutsar I; Heath PT; Hardy P; Linsell L; Jacqz-Aigrain E; Roilides E; Sharland M;
    Trials; 2020 Apr; 21(1):329. PubMed ID: 32293527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
    Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
    Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
    He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin: pharmacokinetics and administration regimens in neonates.
    de Hoog M; Mouton JW; van den Anker JN
    Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
    Demirel B; İmamoglu E; Gursoy T; Demirel U; Topçuoglu S; Karatekin G; Ovali F
    J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
    Jeurissen A; Sluyts I; Rutsaert R
    Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
    Oudin C; Vialet R; Boulamery A; Martin C; Simon N
    Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
    Ginovart Galiana G; Mangues Bafalluy MA; Demestre Guasch X; Farré Riba R; Lopes Santos AP; Altirriba Valls O
    An Esp Pediatr; 1996 Aug; 45(2):167-71. PubMed ID: 8967647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
    Duszynska W; Taccone FS; Hurkacz M; Wiela-Hojenska A; Kübler A
    Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.